Hematologic Neoplasms
Showing 1 - 25 of 82
Tumors, Hematologic Tumors, Hematologic Diseases Trial in Xuzhou (RD13-02 cell infusion)
Recruiting
- Neoplasms
- +2 more
- RD13-02 cell infusion
-
Xuzhou, Jiangsu, ChinaAffiliated hospital of Xuzhou medical college
Jun 7, 2023
Tumors, Hematologic Tumors, Hematologic Diseases Trial in Hefei (RD13-02 cell infusion)
Recruiting
- Neoplasms
- +2 more
- RD13-02 cell infusion
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of University of Science and Techn
Jun 5, 2023
Tumors, Hematologic Tumors, Tumors by Site Trial in Wuhan (RD13-02 cell infusion)
Recruiting
- Neoplasms
- +3 more
- RD13-02 cell infusion
-
Wuhan, Hubei, ChinaUnion Hospital, Huazhong University of Science and Technology
Jun 8, 2023
Prospective Validation of the OHI Index
Recruiting
- HLH
- +4 more
-
Kfar Saba, Israel
- +1 more
May 21, 2023
Hematologic Malignancy, Hematologic Tumors, Hematologic Diseases Trial in Nanjing, Suzhou, Tianjin (Flow Cytometry)
Not yet recruiting
- Hematologic Malignancy
- +2 more
- Flow Cytometry
-
Nanjing, Jiangsu, China
- +2 more
Apr 17, 2023
Tumors, Hematologic Tumors, Tumors by Site Trial in Hangzhou (RD13-02 cell infusion)
Recruiting
- Neoplasms
- +3 more
- RD13-02 cell infusion
-
Hangzhou, Zhejiang, ChinaThe first affiliated hospital of medical college of zhejiang uni
Feb 6, 2023
Hematologic Tumors Trial in France (Allogeneic (Allo) hematopoietic stem cell transplantation)
Completed
- Hematologic Neoplasms
- Allogeneic (Allo) hematopoietic stem cell transplantation
-
Amiens, France
- +13 more
Jan 27, 2023
Tissue Specimens From Solid Tumors or Blood Disorders and Their
Recruiting
- Neoplasms
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Hematologic Tumors, Neutropenia, Anemia Trial in Wuhan (umbilical cord derived mesenchymal stem cells)
Not yet recruiting
- Hematologic Neoplasms
- +5 more
- umbilical cord derived mesenchymal stem cells
-
Wuhan, Hubei, China
- +2 more
Jan 3, 2023
Hematologic Tumors Trial in Canada (Tranexamic Acid)
Recruiting
- Hematologic Neoplasms
- Tranexamic Acid
-
Calgary, Alberta, Canada
- +10 more
Dec 12, 2022
Hematologic Tumors Trial run by the NCI (donor lymphocyte infusion, Cyclophosphamide, Busulfan)
Suspended
- Hematologic Neoplasms
- donor lymphocyte infusion
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 30, 2022
Hematologic Tumors Trial in Nanjing (virtual reality device)
Recruiting
- Hematologic Neoplasms
- virtual reality device
-
Nanjing, Jiangsu, Chinathe First Affiliated Hospital of Nanjing Medical University
Oct 28, 2022
Hypoxic Red Blood Cells for Burns and Hematological Malignancies
Recruiting
- Hematologic Neoplasms
- Burns
- Hypoxic Red Blood Cells
-
Bergen, NorwayHaukeland University Hospital
Sep 19, 2022
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)
Recruiting
- Leukemia
- +19 more
- CYNK-001
-
Denver, Colorado
- +9 more
Sep 9, 2022
Hematologic Tumors, Solid Tumor Trial in Madison (PMMTB (Precision Medicine Molecular Tumor Board))
Recruiting
- Hematologic Neoplasms
- Solid Neoplasm
- PMMTB (Precision Medicine Molecular Tumor Board)
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Jul 7, 2022
Hematologic Tumors, Hemorrhage, Hematopoietic Stem Cell Transplantation Trial in Australia, United Kingdom (Tranexamic acid
Completed
- Hematologic Neoplasms
- +2 more
- Tranexamic acid (TXA).
- Placebo
-
Adelaide, Australia
- +27 more
Jun 20, 2022
Febrile Neutropenia, Solid Tumor, Hematologic Tumors Trial in Clamart, Le Kremlin-Bicêtre (NEUTROSIS)
Completed
- Febrile Neutropenia
- +2 more
- NEUTROSIS
-
Clamart, France
- +2 more
May 2, 2022
Cognitive Impairment, Hematologic Tumors, Hematopoietic Cell Transplant Trial in Birmingham (Lumosity, Lumosity (waitlist
Recruiting
- Cognitive Impairment
- +2 more
- Lumosity
- Lumosity (waitlist control)
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Apr 25, 2022
What Matters Most to Patients: Establishing Validity
Recruiting
- Hematologic Neoplasms
- Assessment Surveys
- Qualitative Interviews
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center
Apr 11, 2022
GVHD, Hematologic Tumors Trial in La Jolla (Cyclophosphamide, abatacept, Methotrexate)
Recruiting
- GVHD
- Hematologic Neoplasms
- Cyclophosphamide
- +3 more
-
La Jolla, CaliforniaUC San Diego Moores Cancer Center
Mar 21, 2022
Cancer of Unknown Origin, Cancer Refractory, Cancer of Stomach Trial in Austria (Genomic testing)
Recruiting
- Cancer of Unknown Origin
- +14 more
- Genomic testing
-
Feldkirch, Austria
- +10 more
Feb 18, 2022
Genomic Sequencing to Find Potential Targets for Personalized
Completed
- Hematologic Neoplasms
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Feb 8, 2022
COVID-19 After Autologous Hematopoietic Stem Cell
Completed
- Covid19
- +4 more
- Autologous stem cell transplantation
-
Uppsala, SwedenUppsala Universitet
Feb 7, 2022
Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals
Recruiting
- Hematologic Neoplasms
- COVID-19 Vaccines
- S-binding IgG, RBD-binding IgG and N-binding IgG immunoassays and SARS-CoV-2 serum neutralization assay, quantitative serum immunoglobulin tests
- +2 more
-
Vilnius, LithuaniaVilnius University Hospital Santaros Klinikos
Dec 27, 2021